Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules

Pooja Virmani; Esther Chung; Alissa A Thomas; Ingo K Mellinghoff; Michael A Marchetti

doi:10.1016/j.jdcr.2015.06.012

Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules

JAAD Case Rep. 2015 Jul 29;1(5):286-8. doi: 10.1016/j.jdcr.2015.06.012. eCollection 2015 Sep.

Authors

Pooja Virmani¹, Esther Chung¹, Alissa A Thomas², Ingo K Mellinghoff³, Michael A Marchetti¹

Affiliations

¹ Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
² Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York.

No abstract available

Keywords: ADR, adverse drug reaction; TMZ, temozolomide; adverse drug reaction; dermal hypersensitivity reaction; panniculitis; rash; temozolomide.

Publication types

Case Reports